Publications by authors named "M Ruiz Frontera"
Lifting COVID-19 mitigation measures in Spain (May-June 2020).
Enferm Infecc Microbiol Clin (Engl Ed)
January 2023
Introduction: The state of alarm was declared in Spain due to the COVID-19 epidemic on March 14, 2020, and established population confinement measures. The objective is to describe the process of lifting these mitigation measures.
Methods: The Plan for the Transition to a New Normality, approved on April 28, contained four sequential phases with progressive increase in socio-economic activities and population mobility.
Lifting COVID-19 mitigation measures in Spain (May-June 2020).
Enferm Infecc Microbiol Clin
January 2023
Introduction: The state of alarm was declared in Spain due to the COVID-19 epidemic on March 14, 2020, and established population confinement measures. The objective is to describe the process of lifting these mitigation measures.
Methods: The Plan for the Transition to a New Normality, approved on April 28, contained four sequential phases with progressive increase in socio-economic activities and population mobility.
Lifting COVID-19 mitigation measures in Spain (May-June 2020).
Enferm Infecc Microbiol Clin (Engl Ed)
June 2021
Article Synopsis
- Spain declared a state of alarm on March 14, 2020, due to COVID-19, implementing confinement measures and later launching a phased plan to lift them, beginning May 4, 2020.
- The transition involved a careful strategy for monitoring and controlling the virus, with decision-making shared between the national government and regional authorities, using specific indicators to assess the situation.
- By June 21, 2020, significant improvements were made, including a decrease in infection rates, increased testing capacity, and better contact tracing, highlighting the importance of data and communication in managing the public health response.
Aims: To test whether communicating cardiovascular diseases (CVD) risk using a novel risk assessment tool (Heart Age) will be able to motivate a population to adopt healthier lifestyles and improve CVD risk profile over the use of a traditional percentage-based tool.
Methods: A single-blind randomized intervention study was carried out in a Caucasian population. A total of 3153 subjects were randomly allocated to one of three study groups: control (conventional medical advice was given to the subjects), Framingham REGICOR (10-year percentage risk score, calibrated to Spanish population was given to the subjects), or Heart Age group (Heart Age tool was administered to the subjects).
Background & Aims: To examine the antiviral activity of boceprevir, a hepatitis C virus (HCV) protease inhibitor, in HCV genotype (G) 2/3-infected patients.
Methods: We assessed boceprevir and telaprevir activity against an HCV G2 and G3 isolates enzyme panel, in replicon, and in phenotypic cell-based assays. Additionally, a phase I study evaluated the antiviral activity of boceprevir monotherapy (200mg BID, 400mg BID, or 400mg TID) vs.